Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
Condition:   T Cell Lymphoma Interventions:   Drug: Mogamulizumab;   Drug: DA-EPOCH Protocol Sponsors:   Tarsheen Sethi;   Kyowa Kirin, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas
Condition:   T Lymphoblastic Leukemia/Lymphoma Intervention:   Drug: Chidamide Sponsor:   Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials